(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid

We are (aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid CAS:76498-22-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid
CAS.NO:  76498-22-1
Synonyms:
(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid

Molecular Formula:C20H23NO5
Molecular Weight:  357.40000

Physical and Chemical Properties:
Density:1.296g/cm3
Boiling point: 581.871ºC at 760 mmHg
Melting point: /
Flash point:305.705ºC
Refractive index:1.602

Specification:
Appearance: /
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Ubenimex CAS:58970-76-6

(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid


Related News: The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.2 – ((1-bencilpiperidin-4-il) metileno) -5,6-dimetoxi-2,3-dihidro-1H-inden-1-ona CAS:120014-07-5 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.methyl 2-bromopentanoate CAS:19129-92-1 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.Ácido 4-fluoro-2-nitrobenzoico CAS:394-01-4 When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.

Related Products
Product Name
Chlorotriethylsilane View Details
2-methylbenzene-1,4-diamine,dihydrochloride View Details
2-Fluoro-4-methyl-5-nitropyridine View Details
5-O-Trityl-2,3,-anhydrothymidine manufacturer 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide manufacturer DIMETHYLCYSTEAMINE HYDROCHLORIDE manufacturer D-Proline tert-Butyl Ester Hydrochloride manufacturer silver,trifluoromethanesulfonate Cas:2923-28-6 manufacturer